[96a5a0]: / output / allTrials / identified / NCT02283320_identified.json

Download this file

577 lines (577 with data), 22.5 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
439
440
441
442
443
444
445
446
447
448
449
450
451
452
453
454
455
456
457
458
459
460
461
462
463
464
465
466
467
468
469
470
471
472
473
474
475
476
477
478
479
480
481
482
483
484
485
486
487
488
489
490
491
492
493
494
495
496
497
498
499
500
501
502
503
504
505
506
507
508
509
510
511
512
513
514
515
516
517
518
519
520
521
522
523
524
525
526
527
528
529
530
531
532
533
534
535
536
537
538
539
540
541
542
543
544
545
546
547
548
549
550
551
552
553
554
555
556
557
558
559
560
561
562
563
564
565
566
567
568
569
570
571
572
573
574
575
576
577
{
"info": {
"nct_id": "NCT02283320",
"official_title": "An Open Label, Multicenter, Phase 2 Study to Determine the Safety and Efficacy of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) as a Second-Line Therapy for Patients With KRAS Mutation Positive or Squamous Cell Non-Small Cell Lung Cancer",
"inclusion_criteria": "* Males or females at least 18 years of age\n* Diagnosis of NSCLC with locally advanced or metastatic disease\n* Positive for KRAS mutation or Squamous cell histology\n* Previously treated with one platinum-based chemotherapy\n* Disease status must be that of measurable and/or evaluable disease\n* Performance status of 0 to 1 on the ECOG Scale\n* Prior chemotherapy completed at least 3 weeks prior to study enrollment\n* Prior radiation therapy allowed to < 25% of the bone marrow\n* Patient compliance and geographic proximity that allow adequate follow-up\n* Adequate organ function\n* Patients with reproductive potential must use contraceptive methods\n* Signed informed consent from patient\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
"exclusion_criteria": "* Active infection\n* Pregnancy or planning to become pregnant\n* Breast feeding\n* Serious concomitant systemic disorders\n* Second primary malignancy\n* Patients who are symptomatic from brain metastasis\n* Presence of detectable (by physical exam) third-space fluid collections\n* More than 1 prior cytotoxic chemotherapy regimen for advanced disease\n* Prior treatment with docetaxel\n* History of severe hypersensitivity reaction to polysorbate 80\n* Peripheral neuropathy at study entry\n* Patients known to be HIV positive\n* Patients known to be seropositive for hepatitis C hepatitis B\n* Congenital long QT syndrome, congestive heart failure, or bradyarrhythmia",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* Males or females at least 18 years of age",
"criterions": [
{
"exact_snippets": "Males or females",
"criterion": "gender",
"requirements": [
{
"requirement_type": "presence",
"expected_value": [
"male",
"female"
]
}
]
},
{
"exact_snippets": "at least 18 years of age",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum age",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "years"
}
}
]
}
]
},
{
"line": "* Diagnosis of NSCLC with locally advanced or metastatic disease",
"criterions": [
{
"exact_snippets": "Diagnosis of NSCLC",
"criterion": "NSCLC diagnosis",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "locally advanced or metastatic disease",
"criterion": "disease stage",
"requirements": [
{
"requirement_type": "stage",
"expected_value": [
"locally advanced",
"metastatic"
]
}
]
}
]
},
{
"line": "* Positive for KRAS mutation or Squamous cell histology",
"criterions": [
{
"exact_snippets": "Positive for KRAS mutation",
"criterion": "KRAS mutation",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "Squamous cell histology",
"criterion": "Squamous cell histology",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Previously treated with one platinum-based chemotherapy",
"criterions": [
{
"exact_snippets": "Previously treated with one platinum-based chemotherapy",
"criterion": "platinum-based chemotherapy",
"requirements": [
{
"requirement_type": "treatment history",
"expected_value": "previously treated"
}
]
}
]
},
{
"line": "* Disease status must be that of measurable and/or evaluable disease",
"criterions": [
{
"exact_snippets": "Disease status must be that of measurable and/or evaluable disease",
"criterion": "disease status",
"requirements": [
{
"requirement_type": "status",
"expected_value": [
"measurable",
"evaluable"
]
}
]
}
]
},
{
"line": "* Performance status of 0 to 1 on the ECOG Scale",
"criterions": [
{
"exact_snippets": "Performance status of 0 to 1 on the ECOG Scale",
"criterion": "ECOG performance status",
"requirements": [
{
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 0,
"unit": "N/A"
},
{
"operator": "<=",
"value": 1,
"unit": "N/A"
}
]
}
}
]
}
]
},
{
"line": "* Prior chemotherapy completed at least 3 weeks prior to study enrollment",
"criterions": [
{
"exact_snippets": "Prior chemotherapy completed at least 3 weeks prior to study enrollment",
"criterion": "prior chemotherapy",
"requirements": [
{
"requirement_type": "completion time",
"expected_value": {
"operator": ">=",
"value": 3,
"unit": "weeks"
}
}
]
}
]
},
{
"line": "* Prior radiation therapy allowed to < 25% of the bone marrow",
"criterions": [
{
"exact_snippets": "Prior radiation therapy allowed ... < 25% of the bone marrow",
"criterion": "prior radiation therapy",
"requirements": [
{
"requirement_type": "extent",
"expected_value": {
"operator": "<",
"value": 25,
"unit": "% of the bone marrow"
}
}
]
}
]
},
{
"line": "* Patient compliance and geographic proximity that allow adequate follow-up",
"criterions": [
{
"exact_snippets": "Patient compliance",
"criterion": "patient compliance",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "geographic proximity",
"criterion": "geographic proximity",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Adequate organ function",
"criterions": [
{
"exact_snippets": "Adequate organ function",
"criterion": "organ function",
"requirements": [
{
"requirement_type": "adequacy",
"expected_value": true
}
]
}
]
},
{
"line": "* Patients with reproductive potential must use contraceptive methods",
"criterions": [
{
"exact_snippets": "Patients with reproductive potential",
"criterion": "reproductive potential",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "must use contraceptive methods",
"criterion": "contraceptive methods",
"requirements": [
{
"requirement_type": "usage",
"expected_value": true
}
]
}
]
},
{
"line": "* Signed informed consent from patient",
"criterions": [
{
"exact_snippets": "Signed informed consent from patient",
"criterion": "informed consent",
"requirements": [
{
"requirement_type": "signed",
"expected_value": true
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "N/A",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "* Active infection",
"criterions": [
{
"exact_snippets": "Active infection",
"criterion": "infection",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Pregnancy or planning to become pregnant",
"criterions": [
{
"exact_snippets": "Pregnancy",
"criterion": "pregnancy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "planning to become pregnant",
"criterion": "pregnancy intention",
"requirements": [
{
"requirement_type": "intention",
"expected_value": false
}
]
}
]
},
{
"line": "* Breast feeding",
"criterions": [
{
"exact_snippets": "Breast feeding",
"criterion": "breast feeding",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* Serious concomitant systemic disorders",
"criterions": [
{
"exact_snippets": "Serious concomitant systemic disorders",
"criterion": "concomitant systemic disorders",
"requirements": [
{
"requirement_type": "severity",
"expected_value": "serious"
}
]
}
]
},
{
"line": "* Second primary malignancy",
"criterions": [
{
"exact_snippets": "Second primary malignancy",
"criterion": "second primary malignancy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Patients who are symptomatic from brain metastasis",
"criterions": [
{
"exact_snippets": "symptomatic from brain metastasis",
"criterion": "brain metastasis",
"requirements": [
{
"requirement_type": "symptoms",
"expected_value": true
}
]
}
]
},
{
"line": "* Presence of detectable (by physical exam) third-space fluid collections",
"criterions": [
{
"exact_snippets": "Presence of detectable (by physical exam) third-space fluid collections",
"criterion": "third-space fluid collections",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
},
{
"requirement_type": "detection method",
"expected_value": "physical exam"
}
]
}
]
},
{
"line": "* More than 1 prior cytotoxic chemotherapy regimen for advanced disease",
"criterions": [
{
"exact_snippets": "More than 1 prior cytotoxic chemotherapy regimen for advanced disease",
"criterion": "prior cytotoxic chemotherapy regimen",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": ">",
"value": 1,
"unit": "N/A"
}
}
]
}
]
},
{
"line": "* Prior treatment with docetaxel",
"criterions": [
{
"exact_snippets": "Prior treatment with docetaxel",
"criterion": "treatment with docetaxel",
"requirements": [
{
"requirement_type": "prior",
"expected_value": true
}
]
}
]
},
{
"line": "* History of severe hypersensitivity reaction to polysorbate 80",
"criterions": [
{
"exact_snippets": "History of severe hypersensitivity reaction to polysorbate 80",
"criterion": "hypersensitivity reaction to polysorbate 80",
"requirements": [
{
"requirement_type": "severity",
"expected_value": "severe"
},
{
"requirement_type": "history",
"expected_value": true
}
]
}
]
},
{
"line": "* Peripheral neuropathy at study entry",
"criterions": [
{
"exact_snippets": "Peripheral neuropathy at study entry",
"criterion": "peripheral neuropathy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Patients known to be HIV positive",
"criterions": [
{
"exact_snippets": "Patients known to be HIV positive",
"criterion": "HIV status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "positive"
}
]
}
]
},
{
"line": "* Patients known to be seropositive for hepatitis C hepatitis B",
"criterions": [
{
"exact_snippets": "seropositive for hepatitis C",
"criterion": "hepatitis C seropositivity",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "seropositive for ... hepatitis B",
"criterion": "hepatitis B seropositivity",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Congenital long QT syndrome, congestive heart failure, or bradyarrhythmia",
"criterions": [
{
"exact_snippets": "Congenital long QT syndrome",
"criterion": "congenital long QT syndrome",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "congestive heart failure",
"criterion": "congestive heart failure",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "bradyarrhythmia",
"criterion": "bradyarrhythmia",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}